SUPERSTRING CAPITAL MANAGEMENT LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001931118

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2025 · 35 positions · Total reported value $101.50M · Top-10 concentration 53.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.1% · 8 new · 9 cut · 11 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.6% · vs SPY +11.8% · Prev Value $139.97M — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, SUPERSTRING CAPITAL MANAGEMENT LP disclosed 35 equity positions with a combined reported value of $101.50M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were ZLAB ($6.80M), CDTX ($6.56M), TERN ($5.93M). By sector, the heaviest allocations are Health Care 81.3%, Other 18.7%. Versus the prior quarter, allocation shifted toward Health Care (+3.7pp) and away from Other (-3.4pp).

Versus the prior quarter, SUPERSTRING CAPITAL MANAGEMENT LP opened 8 new positions, trimmed 9 and fully exited 11, a turnover rate of 65.1% of positions. The portfolio's overlap with the prior quarter was 37% of names.

The largest new positions opened in Q3 2025 were CDTX ($6.56M), IMVT ($5.50M), SMMT ($4.08M).

Of the 11 positions fully exited versus the prior quarter, the largest were VRNA ($6.52M), NBIX ($5.10M), RARE ($4.74M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • CDTX CIDARA THERAPEUTICS INC · $6.56M
  • IMVT IMMUNOVANT INC · $5.50M
  • SMMT SUMMIT THERAPEUTICS INC · $4.08M
  • IQV IQVIA HLDGS INC · $3.63M
  • REGN REGENERON PHARMACEUTICALS · $3.60M
  • DRUG BRIGHT MINDS BIOSCIENCES INC · $3.27M
  • NKTR NEKTAR THERAPEUTICS · $2.92M
  • AVTX AVALO THERAPEUTICS INC · $2.39M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $6.52M
  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $5.10M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $4.74M
  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $3.88M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $2.82M
  • CYTK CYTOKINETICS INC · prev qtr: $2.02M
  • UTHR UNITED THERAPEUTICS CORP DEL · prev qtr: $1.40M · history
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $1.34M

Insider Transactions (Form 4)

Latest SUPERSTRING CAPITAL MANAGEMENT LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Superstring Capital Management, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 32 positions worth $158.38M in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118766 (status: Approved), registered 2020-05-20
  • Regulatory AUM (Form ADV): $339.50M as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: superstringcap.com

Portfolio Structure

  • 32 positions · $158.38M reported value (Q2 2026)
  • Top 10 holdings = 63.8% of reported value
  • Largest position: COGT (COGENT BIOSCIENCES INC) at 8.4%
  • Average position size: $4.95M

Sector Tilt

  • Health Care 99.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 8 new, 12 added, 9 reduced, 11 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.3%
Other 18.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 200.63K $6.80M 6.70%
6.70%
Add
2 68.46K $6.56M 6.46%
6.46%
New
3 789.65K $5.93M 5.84%
5.84%
Reduce
4 384.65K $5.65M 5.57%
5.57%
Add
5 341.35K $5.50M 5.42%
5.42%
New
6 40.89K $5.39M 5.31%
5.31%
Reduce
7 361.41K $5.19M 5.11%
5.11%
Reduce
8 1.31M $4.67M 4.61%
4.61%
Add
9 88.66K $4.60M 4.54%
4.54%
Reduce
10 197.25K $4.08M 4.01%
4.01%
New
11 19.11K $3.63M 3.58%
3.58%
New
12 1.54M $3.61M 3.56%
3.56%
Add
13 6.40K $3.60M 3.55%
3.55%
New
14 53.95K $3.27M 3.22%
3.22%
New
15 51.27K $2.92M 2.87%
2.87%
New
16 19.79K $2.85M 2.81%
2.81%
Add
17 175.90K $2.78M 2.74%
2.74%
Reduce
18 188.08K $2.39M 2.35%
2.35%
New
19 50.41K $2.38M 2.34%
2.34%
New
20 96.67K $2.15M 2.11%
2.11%
Reduce
21 33.17K $1.94M 1.91%
1.91%
New
22 119.29K $1.87M 1.84%
1.84%
Add
23 87.91K $1.75M 1.73%
1.73%
Hold
24 360.00K $1.57M 1.54%
1.54%
Hold
25 95.08K $1.50M 1.48%
1.48%
New
26 39.52K $1.47M 1.45%
1.45%
New
27 20.36K $1.35M 1.33%
1.33%
New
28 53.63K $1.28M 1.26%
1.26%
Reduce
29 89.35K $1.07M 1.06%
1.06%
Reduce
30 34.45K $888.44K 0.88%
0.88%
Add
31 150.31K $858.28K 0.85%
0.85%
New
32 57.64K $729.20K 0.72%
0.72%
New
33 139.89K $528.77K 0.52%
0.52%
New
34 250.00K $505.00K 0.50%
0.50%
Hold
35 462.96K $230.56K 0.23%
0.23%
Hold

FAQ

What did SUPERSTRING CAPITAL MANAGEMENT LP buy in 2025-Q3?

In its 2025-Q3 13F filing, SUPERSTRING CAPITAL MANAGEMENT LP reported 35 equity positions worth $101.50M in aggregate; its largest disclosed positions were ZLAB ($6.80M), CDTX ($6.56M), TERN ($5.93M).

How large is SUPERSTRING CAPITAL MANAGEMENT LP's portfolio?

SUPERSTRING CAPITAL MANAGEMENT LP reported $101.50M of long equity holdings across 35 positions as of 2025-Q3. Top-10 holdings account for 53.6% of reported value.

What is SUPERSTRING CAPITAL MANAGEMENT LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/superstring-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →